Advertisement
Table 2 Treatment characteristics
| Treatment characteristics | Arm A (cisplatin 100 mg/m2) | Arm B (cisplatin 40 mg/m2) | p |
|---|---|---|---|
| N = 26 | N = 24 | ||
| Cisplatin dose (mg/m2) | |||
| Mean (range) | 208.5 (100–300) | 200.4 (80–280) | 0.568 |
| Cisplatin ≥ 200 mg/m2 | |||
| No | 3 (11.5%) | 9 (37.5%) | 0.047* |
| Yes | 23 (88.5%) | 15 (62.5%) | |
| RT dose (cGy) | |||
| Mean (range) | 6477.7 (4820–6600) | 6250.0 (1400–7200) | 0.361 |
| RT dose ≥ 6000 cGy | |||
| No | 2 (7.7%) | 2 (8.3%) | 1.000 |
| Yes | 24 (92.3%) | 22 (91.7%) | |
| RT duration (weeks) | |||
| Mean (range) | 6.8 (4.6–9.1) | 6.6 (1.7–9.0) | 0.506 |
| RT duration > 8 weeks | |||
| No | 24 (92.3%) | 20 (83.3%) | 0.409 |
| Yes | 2 (7.7%) | 4 (16.7%) | |
